Direkt zum Inhalt

News

Cardiogenic shock: do we need a paradigm shift?

The paradigm shift in the management of cardiogenic shock: moving from pure mechanical left ventricular unloading to neurohumoral and anti- inflammatory blockade with or without left ventricular mechanical assistance...

Read full article (European Heart Journal (2024) 00, 1–3)

Management of cardiac sarcoidosis

A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC

Read full article (European Heart Journal (2024) 00, 1–30)

 

Am Puls der Herzmedizin

Herz-Kreislauf-Erkrankungen sind die häufigste Todesursache in der Schweiz, entsprechend intensiv wird das Pumporgan erforscht. Sechs innovative Projekte.

1 — KI für Symptome bei Frauen Europaweite Analyse, Universität Zürich

Erfahren Sie mehr HIER (Horizonte, Dezember 2023)

Cardiac Sarcoidosis – An Underrecognized Myocardial Disease

Sarcoidosis is a multisystemic, chronic inflammatory disorder involving lymph nodes and lungs characterized by a non-caseating, epithelioid cell granulomatous inflammation of affected organs. Cardiac involvement has been reported in 5-30% depending on the diagnostic criteria.

Read full article (Cardiovasc Med | 2024;27(1):1–3)

 

Evaluation and management of patients with coronary chronic total occlusions considered for revascularisation

Chronic total occlusions (CTOs) of coronary arteries can be found in the context of chronic or acute coronary syndromes; sometimes they are an incidental finding in those apparently healthy individuals undergoing imaging for preoperative risk assessment.

Read full article (EuroIntervention, 2024;20:e174-e184)

Screening and prevention in congenital heart disease: Whom, when, and how?

The treatment of congenital heart disease has been one of the triumphs of modern cardiology and cardiac surgery. Most children born with congenital heart disease now survive to adulthood and this has created a new specialty with many challenges.

Read full article (International Journal of Cardiology Congenital Heart Disease 14 (2023) 100480)

Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans

Acute myocardial infarctions are a common cause of heart failure and early death in the elderly. Recent studies challenge the idea that a molecule called growth differentiation factor 11 (GDF11) superfamily exerts heart-rejuvenating effects, as initially proposed by impactful work.

Read full article (Cardiovascular Research (2023) 00, 1–14)

Effects of SARS-COV-2 infection on outcomes in patients hospitalized for acute cardiac conditions. A prospective, multicenter cohort study

This study sought to assess the effect of concomitant SARS-COV-2 infection on clinical outcomes of hospitalized patients.

Read full article (Front. Cardiovasc. Med., 13 October 2023)

 

Towards personalized cardiovascular care: Global Registry of Acute Coronary Events 3.0 score heralds artificial intelligence era

Accurate risk assessment is key to advance personalized treatment strategies in the heterogeneous group of patients with acute coronary syndromes (ACS).

Read full article (European Heart Journal (2023) 00, 1–2)

Circulating Long Noncoding RNA Signatures Associate With Incident Diabetes in Older Adults: A Prospective Analysis From the VITA Cohort Study

Long noncoding RNAs (lncRNAs) are involved in diabetogenesis in experimental models, yet their role in humans is unclear. The paper investigates whether circulating lncRNAs associate with incident type 2 diabetes in older adults.

Read full article (Diabetes Care 2023;46(6):1239–1244)